# Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas

> **NCT06000553** · NA · NOT_YET_RECRUITING · sponsor: **Institut Paoli-Calmettes** · enrollment: 360 (estimated)

## Conditions studied

- PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS

## Interventions

- **OTHER:** blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.

## Key facts

- **NCT ID:** NCT06000553
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-30
- **Primary completion:** 2028-10-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06000553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06000553, "Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06000553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*